First reported 23 hours ago -
Updated 23 hours ago -
Over a five-year period of time, only Pharmacyclics (PCYC) has performed better than Jazz Pharmaceuticals
(JAZZ). Yet, despite Jazz's five-year 8,000% return, the stock rarely finds itself in the headlines or even widely covered by analysts. In 2013, ...
[Published Seeking Alpha - 23 hours ago]